# ReShape Lifesciences, Inc. – FDA Inspection, May 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/e4e54b6b-de8f-410c-9f4c-67b3c01d41f9
Source feed: FDA_Inspections

> FDA inspection 1091756 of ReShape Lifesciences, Inc., May 22, 2019. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 820. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091756
- Company Name: ReShape Lifesciences, Inc.
- Inspection Date: 2019-05-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- [FDA Inspection 1036574 - 2017-12-18](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/feb5d6d2-62f7-407c-accc-83f1f06b20bc)
- FDA Inspection 974242 - 2016-04-22
- [FDA Inspection 856112 - 2013-11-25](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/990239b7-09ea-419b-9b89-911122298ba3)
- FDA Inspection 838101 - 2013-06-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/benjamin-w-anderson/a3c0961c-6a83-4bd7-abb8-02c5c8dd3a35)

Company: https://www.keypedia.com/companies/reshape-lifesciences-inc/740415bf-ee64-46b0-91ff-3ff435f3769d

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7